Étude comparative de type exposé non exposé CBP-COVID évaluant les conséquences cliniques, thérapeutiques et pronostiques de la 1(re) vague à SARS-Cov2 et du confinement sur les pa...

por Molinier, O., Marcq, M., Chene, A., Masson, P., Denis, F., Bigot, F., Saulnier, P.
Publicado 2023

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

por Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J
Publicado 2004

509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study

por Molinier, O., Falchero, L., Monnet, I., Decroisette, C., Neidhart, A-C., Redureau, E., Chiappa, A-M., Bigot, F., Bedossa, A., Amrane, K., Jeandeau, S., Dujon, C., Bugnet, A-S., Bonnefoy, P., Alizon, C., Meyer, N., Couraud, S., Cortot, A., Letierce, A., Debieuvre, D.
Publicado 2022

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

por Molinier, O., Besse, B., Barlesi, F., Audigier-Valette, C., Friard, S., Monnet, I., Jeannin, G., Mazières, J., Cadranel, J., Hureaux, J., Hilgers, W., Quoix, E., Coudert, B., Moro-Sibilot, D., Fauchon, E., Westeel, V., Brun, P., Langlais, A., Morin, F., Souquet, P.J., Girard, N.
Publicado 2021

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of...

por Couraud, S., Cortot, A. B., Greillier, L., Gounant, V., Mennecier, B., Girard, N., Besse, B., Brouchet, L., Castelnau, O., Frappé, P., Ferretti, G. R., Guittet, L., Khalil, A., Lefebure, P., Laurent, F., Liebart, S., Molinier, O., Quoix, E., Revel, M.-P., Stach, B., Souquet, P.-J., Thomas, P., Trédaniel, J., Lemarié, E., Zalcman, G., Barlési, F., Milleron, B.
Publicado 2013